Efficacy of Two Types of Non-invasive Erector Spinae Muscle Taut Band Therapy in University Students With Low Back Pain

NCT ID: NCT05279794

Last Updated: 2022-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-21

Study Completion Date

2022-05-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Non-specific low back pain can be caused by the presence of active trigger points in the muscles of the lumbopelvic region. Trigger points are defined as hypersensitive points within a taut band of a musculoskeletal system that cause pain during contraction, stretching, or stimulation of said muscle. If these points are active, they can trigger referred pain, local tenderness, and vegetative responses. There is scientific evidence of the improvement of the treatment of these points through non-invasive manual techniques. The objective of this study will be to determine the effect of Strain Counterstrain and Myofascial Induction techniques in subjects with low back pain secondary to the presence of active trigger points in the lumbopelvic region. Hyperexcitable myofascial trigger points located within a taut band of skeletal muscle or fascia cause referred pain, local tenderness, and autonomic changes. The scientific data refer to an immediate improvement in the symptoms of these active points treated with manual therapy. Based on these factors, the objective of the study is to determine the effect of the combined therapy of the Strain Counterstrain technique and Myofascial Induction in participants with the presence of an active trigger point in the erector spinae muscle.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The treatment will last a total of 15 minutes accompanied by a baseline assessment and after 10 minutes of the intervention in 2 experimental groups and a placebo group, of no-pain positioning. In addition to basic indices and scales of low back pain and disability caused by low back pain, it is intended to measure flexibility, range of motion, proprioception and cognition through software with sensors of the latest technology when representing reliable results in differences between techniques.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain Trigger Point Pain, Myofascial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Jones Group (Strain Counterstrain)

Jones Group consist in 90 seconds in a ralease positioning of no pain in muscle acortation

Group Type EXPERIMENTAL

Jones Group (Strain Counterstrain)

Intervention Type OTHER

No pain positioning technique with diaphragmatic breathing

Myofascial Induction Group

Myofascial Induction Group consist in 15 minutes of superficial and deep lumbar fascia maneuvers

Group Type ACTIVE_COMPARATOR

Myofascial Induction Group

Intervention Type OTHER

Myofascial Induction technique on the lumbar fascia

Placebo Group

Placebo Group only have to mantain no pain positioning for 3 minutes

Group Type PLACEBO_COMPARATOR

Placebo Group

Intervention Type OTHER

No pain positioning of participants

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Jones Group (Strain Counterstrain)

No pain positioning technique with diaphragmatic breathing

Intervention Type OTHER

Myofascial Induction Group

Myofascial Induction technique on the lumbar fascia

Intervention Type OTHER

Placebo Group

No pain positioning of participants

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presence of low back pain
* Presence of active trigger point in the erector spinae as described by Lawrence H. Jones

Exclusion Criteria

* Participants who present dizziness, vertigo;
* Previous or scheduled surgeries in the lumbar spine and/or lower extremities;
* Suspicion of serious fractures or pathologies (tumor, inflammation, infection, rheumatological disorder, systemic disease, presence of fever);
* Diagnosis of radiculopathy or neuropathy;
* Structural deformity in the spine; spondyloarthropathy, disabling pain and physical disability;
* Use of pain relievers or anti-inflammatory drugs in the last 48 hours;
* Neurological or psychiatric disorder;
* Presence or suspicion of pregnancy
Minimum Eligible Age

19 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Católica San Antonio de Murcia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Juan Martínez Fuentes

Study Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidad Católica de Murcia

Murcia, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CE012207

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.